Radiogenic Vaginal Angiosarcoma: a Clinical Case

Background. Vaginal sarcomas are rare malignant mesenchymal neoplasms. Incidence rate of vulvar and vaginal sarcomas ranges from 1 to 3%. Vaginal sarcomas are usually represented by leiomyosarcomas in reproductive-age women. More seldom are soft tissue fibrosarcomas, angiosarcomas, malignant fi brous histiocytomas and alveolar soft tissue sarcomas. Tumours induced by prior radiation therapy deserve special concern. In oncogynaecology, radiation therapy is commonly applied in cervical and endometrial cancer therapy. According to some evidence, average development time of a secondary tumour after completion of radiation therapy is 10.8 years. The relative risk of vaginal cancer increases by a factor of 300 after radiation therapy.

Materials and methods. The reported clinical case represents a rare vaginal tumour, angiosarcoma, developed 26 years after radiation therapy for gynaecological cancer.

Results and discussion. A 78 years-old patient underwent combined tumourectomy of the posterior vaginal wall with resection of the anterior rectal wall and application of preventive transversostoma. No postoperative complications were observed.

Conclusion. Surgical treatment is a method of choice with patients of such kind and allows local containment of the disease.

1. Patil R.R., Vijay N.R., Joshi S. An unusual presentation of vaginal leiomyoma. J Midlife Health. 2019;10(4):204–5. DOI: 10.4103/jmh.JMH_40_19

2. Devereaux K.A., Schoolmeester J.K. Smooth muscle tumors of the female genital tract. Surg Pathol Clin. 2019;12(2):397–455. DOI: 10.1016/j.path.2019.02.004

3. Cao S., Liu Y., Bai X., Wang L. A case report of uterine leiomyosarcoma. Onco Targets Th er. 2019;12:8583–6. DOI: 10.2147/OTT.S218222

4. Sun C., Zou J., Wang Q., Wang Q., Han L., Batchu N., et al. Review of the pathophysiology, diagnosis, and therapy of vulvar leiomyoma, a rare gynecological tumor. J Int Med Res. 2018;46(2):663–74. DOI: 10.1177/0300060517721796

5. Harada K., Ishikawa Y., Fujiwara H., Ishihara G. Female paraurethral leiomyoma successfully excised through a vaginal approach: A case report. J Obstet Gynaecol Res. 2018;44(6):1174–6. DOI: 10.1111/jog.13641

6. Sayeed S., Xing D., Jenkins S.M., Weisman P.S., Buehler D., Warmke L., et al. Criteria for risk stratifi cation of vulvar and vaginal smooth muscle tumors: an evaluation of 71 cases comparing proposed classifi cation systems. Am J Surg Pathol. 2018;42(1):84–94. DOI: 10.1097/PAS.0000000000000920

7. Viau M., Plante M., Renaud M.C., Grondin K., Morin C. Proposed novel nomenclature of vulvar smooth muscle tumors; a case of Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP) of the vulva. Gynecol Oncol Rep. 2017;20:1–3. DOI: 10.1016/j.gore.2017.01.006

8. Egbe T.O., Kobenge F.M., Metogo J.A.M., Manka’a Wankie E., Tolefac P.N., Belley-Priso E. Vaginal leiomyoma: medical imaging and diagnosis in a resource low tertiary hospital: case report. BMC Womens Health. 2020;20(1):12. DOI: 10.1186/s12905-020-0883-2

9. Almond L.M., Charalampakis M., Ford S.J., Gourevitch D., Desai A. Myeloid sarcoma: presentation, diagnosis, and treatment. Clin Lymphoma Myeloma Leuk. 2017;17(5):263–7. DOI: 10.1016/j.clml.2017.02.027

10. Kaur V., Swami A., Alapat D., Abdallah A.O., Motwani P., Hutchins L.F., et al. Clinical characteristics, molecular profi le and outcomes of myeloid sarcoma: a single institution experience over 13 years. Hematology. 2018;23(1):17–24. DOI: 10.1080/10245332.2017.1333275

11. Wang H.Q., Li J. Clinicopathological features of myeloid sarcoma: report of 39 cases and literature review. Pathol Res Pract. 2016;212(9):817–24. DOI: 10.1016/j.prp.2016.06.014

12. Pileri S.A., Ascani S., Cox M.C., Campidelli C., Bacci F., Piccioli M., et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia. 2007;21(2):340–50. DOI: 10.1038/sj.leu.2404491

13. Voruz S., Cairoli A., Naveiras O., de Leval L., Missiaglia E., Homicsko K., et al. Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma. Haematologica. 2018;103(1):e39–41. DOI: 10.3324/haematol.2017.179150

14. Hayase E., Kurosawa M., Yonezumi M., Suzuki S., Suzuki H. Aggressive sporadic histiocytic sarcoma with immunoglobulin heavy chain gene rearrangement and t(14;18). Int J Hematol. 2010;92(4):659–63. DOI: 10.1007/s12185-010-0704-8

15. Safronova K.V., Artem’eva A.S., Kozlova E.N., Sidoruk A.A., Kutusheva G.F., Bakhidze E.V., et al. Rare vulvar malignancies: sarcomas, melanoma, Paget’s disease. Obstetrics and Gynecology. 2020;(S1):121–130 (In Russ.). DOI: 10.18565/aig.2020.1suppl.121-130

16. Filatova E.I. Primary vaginal cancer. Diagnostics and treatment tactics. Practical oncology. 2006;7(4):228–35 (In Russ.).